Clinico-biological features, treatment and survival of 457 patients with histological Grades 3A and 1-2 follicular lymphoma mostly treated with immunochemotherapy

被引:12
|
作者
Mercadal, Santiago [1 ]
Pomares, Helena [1 ]
Sancho, Juan M. [2 ]
Climent, Fina [3 ]
Garcia, Olga [2 ]
Encuentra, Maite [1 ]
Domingo-Domenech, Eva [1 ]
Sorigue, Marc [2 ]
Moreno, Miriam [2 ]
Oliveira, Ana C. [1 ]
Ribera, Josep-Maria [2 ]
Fernandez de Sevilla, Alberto [1 ]
Gonzalez-Barca, Eva [1 ]
机构
[1] Univ Barcelona, Hosp Duran & Reynals, IDIBELL, Dept Haematol,Catalan Inst Oncol, Barcelona, Spain
[2] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Dept Haematol, Badalona, Spain
[3] Univ Barcelona, Bellvitge Hosp, Dept Pathol, Barcelona, Spain
关键词
follicular lymphoma; histological grades; anthracyclines; immunochemotherapy; outcome; ANTHRACYCLINE; THERAPY; 3B;
D O I
10.1111/bjh.13502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:470 / 473
页数:4
相关论文
共 4 条
  • [1] Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1-2 follicular lymphoma: a real-world multicenter study
    Zha, Jie
    Chen, Qinwei
    Ye, Jingjing
    Yu, Haifeng
    Yi, Shuhua
    Zheng, Zhong
    Xu, Wei
    Li, Zhifeng
    Ping, Lingyan
    He, Xiaohua
    Zhang, Liling
    Li, Caixia
    Xie, Ying
    Chen, Feili
    Sun, Xiuhua
    Su, Liping
    Zhang, Huilai
    Fan, Liyuan
    Lin, Zhijuan
    Yang, Haiyan
    Zhao, Weili
    Qiu, Lugui
    Li, Zhiming
    Song, Yuqin
    Xu, Bing
    BIOMARKER RESEARCH, 2023, 11 (01)
  • [2] RESULTS OF FDG PET-CT IMAGING BEFORE AND AFTER THE INDUCTION TREATMENT ARE RELATED TO DIFFERENT CLINICO-BIOLOGICAL FEATURES AND CAN PREDICT THE OUTCOME OF PATIENTS WITH FOLLICULAR LYMPHOMA (FL)
    Gainza, E.
    Setoain, X.
    Sanchez-Gonzalez, B.
    Gutierrez, G.
    Martinez, A.
    Rodriguez, S.
    Colomo, L.
    Martinez, A.
    Gine, E.
    Campo, E.
    Salar, A.
    Lopez-Guillermo, A.
    ANNALS OF ONCOLOGY, 2011, 22 : 184 - 184
  • [3] IMPACT ON SURVIVAL ACCORDING TO HISTOLOGICAL GRADE (1-2 VS 3A) IN A SERIES OF 128 PATIENTS DIAGNOSED OF FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA. EXPERIENCE IN ICO-HOSPITAL DURAN I REYNALS.
    Marin, H.
    Vilchez, S.
    Esteller, F.
    Domingo-Domenech, E.
    Ramos, A.
    Henao, V.
    de Sevilla Ribosa, A.
    Gonzalez-Barca, E.
    HAEMATOLOGICA, 2013, 98 : 639 - 639
  • [4] Differences in clinical characteristics and outcomes between patients with grade 3a and grades 1–2 follicular lymphoma: a real-world multicenter study
    Jie Zha
    Qinwei Chen
    Jingjing Ye
    Haifeng Yu
    Shuhua Yi
    Zhong Zheng
    Wei Xu
    Zhifeng Li
    Lingyan Ping
    Xiaohua He
    Liling Zhang
    Caixia Li
    Ying Xie
    Feili Chen
    Xiuhua Sun
    Liping Su
    Huilai Zhang
    Liyuan Fan
    Zhijuan Lin
    Haiyan Yang
    Weili Zhao
    Lugui Qiu
    Zhiming Li
    Yuqin Song
    Bing Xu
    Biomarker Research, 11